APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors
Clinical trial NCT04785196 · RECRUITING
Trial details
- NCT number
- NCT04785196
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2026-04-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.